PCT
PureCycle Technologies, Inc.
There isn't enough reported data to score PCT yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
PCT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
PCT's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
PCT PE Valuation
PCT has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
PCT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect PCT's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PCT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.46 | +$0.24 |
| Q1 2026 | -$1.47 | -$0.29 |
| Q4 2025 | -$1.21 | +$0.54 |
| Q3 2025 | -$1.47 | $0.00 |
PCT is still losing money, but less than at its worst: $1.46 per share over the past year, against $1.75 at its worst in late 2024.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB has the edge over PCT on earnings, with more consistent year-over-year improvement.
PCT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3M | -3.3% |
| Q2 2026 | $4.5M | +173% |
| Q1 2026 | $4.1M | +161% |
PCT's revenue is growing: $2M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1595% | +7.5 points |
| Q2 2026 | -916% | +1847 points |
| Q1 2026 | -1013% | +1375 points |
| Q4 2025 | -2196% | N/A |
| Q3 2025 | -1602% | N/A |
| Q2 2025 | -2764% | N/A |
| Q1 2025 | -2387% | N/A |
PCT's operating margin was −1595% last quarter, up 7.5 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over PCT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over PCT on profitability, with a higher operating margin.
PCT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.1M | +$3.2M |
| Q2 2026 | -$81.8M | -$36.4M |
| Q1 2026 | -$46.1M | +$7.8M |
| Q4 2025 | -$42M | +$11.4M |
| Q3 2025 | -$42.4M | +$291K |
| Q2 2025 | -$45.3M | +$5.5M |
| Q1 2025 | -$53.9M | -$346K |
| Q4 2024 | -$53.4M | -$8.6M |
PCT has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
PCT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +3.8M shares |
| 1 year | +2.5% | +4.6M shares |
| 3 years | +13% | +20.7M shares |
| 5 years | +578% | +157M shares |
PCT has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $279,000 |
| Q2 2026 | $295,000 |
| Q1 2026 | $2.2M |
| Q4 2025 | $401,000 |
| Q3 2025 | $1.7M |
| Q2 2025 | $1.1M |
| Q1 2025 | $1.7M |
| Q4 2024 | $440,000 |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PCT Net Leverage
PCT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PCT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 6.2 | Oversold |
PCT's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
PCT PE vs Industrials Sector
PCT has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
PCT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.25 | 45% below |
| 20 week MA | $5.24 | 66% below |
| 50 week MA | $7.33 | 75% below |
| 100 week MA | $9.03 | 80% below |
| 200 week MA | $8.02 | 78% below |
PCT is in a downtrend: it's below all five of its weekly moving averages, and 78% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over PCT on trend strength, trading above more of its moving averages.
PCT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.2 | $16.2 | +59% |
| 2021 | $16.2 | $10.2 | -37% |
| 2022 | $10.2 | $6.49 | -36% |
| 2023 | $6.49 | $4.05 | -38% |
| 2024 | $4.05 | $10.6 | +161% |
| 2025 | $10.6 | $9.01 | -15% |
| 2026 YTD | $9.01 | $1.80 | -80% |
PCT has finished lower in four of the last six years. It's down 80% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over PCT on returns for 2026, with the stronger performance.